Antibody response to COVID-19 vaccination in patients with lymphoma

Patients with lymphoma are at increased risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); therefore, evaluation of SARS-CoV-2 vaccination efficacy is essential. We conducted a prospective observational study to monitor the antibody response in 500 patients with lymphoma after SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Narita, Kentaro, Nakaji, So, Tabata, Rikako, Terao, Toshiki, Kuzume, Ayumi, Tsushima, Takafumi, Ikeda, Daisuke, Fukumoto, Ami, Miura, Daisuke, Takeuchi, Masami, Doi, Masahiro, Umezawa, Yuka, Otsuka, Yoshihito, Takamatsu, Hiroyuki, Matsue, Kosei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859496/
https://www.ncbi.nlm.nih.gov/pubmed/35188650
http://dx.doi.org/10.1007/s12185-022-03305-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859496/
https://www.ncbi.nlm.nih.gov/pubmed/35188650
http://dx.doi.org/10.1007/s12185-022-03305-z

Ejemplares similares